FKGK11 is a potent and selective inhibitor of GVIA iPLA2 (Group VIA calcium-independent phospholipase A2). FKGK11 can be used for the research of ovarian cancer and neurological disorders such as peripheral nerve injury and multiple sclerosis[1][2].
Molecular Weight:
280.23
CAS Number:
[1071000-98-0]
Formula:
C13H13F5O
Target:
Phospholipase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
